Cargando…

Long-term visual outcome in idiopathic intracranial hypertension

OBJECTIVE: To characterize the course, outcome, and risk of relapse or late worsening in a clearly defined cohort of idiopathic intracranial hypertension (IIH) over a long period of follow-up. MATERIALS AND METHODS: Retrospective chart review of patients with definite IIH was evaluated at the Sree C...

Descripción completa

Detalles Bibliográficos
Autores principales: Baheti, N. N., Nair, M., Thomas, S. V.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098517/
https://www.ncbi.nlm.nih.gov/pubmed/21633609
http://dx.doi.org/10.4103/0972-2327.78044
_version_ 1782203974237028352
author Baheti, N. N.
Nair, M.
Thomas, S. V.
author_facet Baheti, N. N.
Nair, M.
Thomas, S. V.
author_sort Baheti, N. N.
collection PubMed
description OBJECTIVE: To characterize the course, outcome, and risk of relapse or late worsening in a clearly defined cohort of idiopathic intracranial hypertension (IIH) over a long period of follow-up. MATERIALS AND METHODS: Retrospective chart review of patients with definite IIH was evaluated at the Sree Chitra Tirunal Institute for Medical Sciences and Technology between 1998 and 2006. Patients’ demographic data, clinical, neuro-ophthalmic examinations, and treatment details were abstracted. Patients were further categorized into three groups based on whether they improved, worsened, or relapsed on follow-up. Final visual outcome of each patient was defined according to grading of the worse eye at the last visit. Statistical analysis included t test to compare group means and chi-square test to compare proportions. RESULTS: Of the 43 women included, visual impairment was observed in 80 eyes (93%) at presentation and it was moderate to severe in 14%. The mean CSF opening pressure at presentation did not differ significantly in those with visual impairment compared to those with normal vision. Those having early severe visual impairment had significantly higher (P = 0.015) likelihood of severe visual impairment on last follow-up. Of the total, 34 patients (79%) improved, 4 (9.3%) relapsed on follow-up after period of stability, and 5 (11.6%) worsened over 56 months follow-up (range, 26-132 months). The groups were comparable, except those who improved were younger (P<0.05). At last examination, 9% had significant vision loss. CONCLUSION: IIH patients can have delayed worsening or relapses and about tenth of patients can have permanent visual loss early or late in the course of the disease. All patients with IIH need to be kept under long-term follow-up, with regular monitoring of visual functions.
format Text
id pubmed-3098517
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30985172011-06-01 Long-term visual outcome in idiopathic intracranial hypertension Baheti, N. N. Nair, M. Thomas, S. V. Ann Indian Acad Neurol Original Article OBJECTIVE: To characterize the course, outcome, and risk of relapse or late worsening in a clearly defined cohort of idiopathic intracranial hypertension (IIH) over a long period of follow-up. MATERIALS AND METHODS: Retrospective chart review of patients with definite IIH was evaluated at the Sree Chitra Tirunal Institute for Medical Sciences and Technology between 1998 and 2006. Patients’ demographic data, clinical, neuro-ophthalmic examinations, and treatment details were abstracted. Patients were further categorized into three groups based on whether they improved, worsened, or relapsed on follow-up. Final visual outcome of each patient was defined according to grading of the worse eye at the last visit. Statistical analysis included t test to compare group means and chi-square test to compare proportions. RESULTS: Of the 43 women included, visual impairment was observed in 80 eyes (93%) at presentation and it was moderate to severe in 14%. The mean CSF opening pressure at presentation did not differ significantly in those with visual impairment compared to those with normal vision. Those having early severe visual impairment had significantly higher (P = 0.015) likelihood of severe visual impairment on last follow-up. Of the total, 34 patients (79%) improved, 4 (9.3%) relapsed on follow-up after period of stability, and 5 (11.6%) worsened over 56 months follow-up (range, 26-132 months). The groups were comparable, except those who improved were younger (P<0.05). At last examination, 9% had significant vision loss. CONCLUSION: IIH patients can have delayed worsening or relapses and about tenth of patients can have permanent visual loss early or late in the course of the disease. All patients with IIH need to be kept under long-term follow-up, with regular monitoring of visual functions. Medknow Publications 2011 /pmc/articles/PMC3098517/ /pubmed/21633609 http://dx.doi.org/10.4103/0972-2327.78044 Text en © Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Baheti, N. N.
Nair, M.
Thomas, S. V.
Long-term visual outcome in idiopathic intracranial hypertension
title Long-term visual outcome in idiopathic intracranial hypertension
title_full Long-term visual outcome in idiopathic intracranial hypertension
title_fullStr Long-term visual outcome in idiopathic intracranial hypertension
title_full_unstemmed Long-term visual outcome in idiopathic intracranial hypertension
title_short Long-term visual outcome in idiopathic intracranial hypertension
title_sort long-term visual outcome in idiopathic intracranial hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098517/
https://www.ncbi.nlm.nih.gov/pubmed/21633609
http://dx.doi.org/10.4103/0972-2327.78044
work_keys_str_mv AT bahetinn longtermvisualoutcomeinidiopathicintracranialhypertension
AT nairm longtermvisualoutcomeinidiopathicintracranialhypertension
AT thomassv longtermvisualoutcomeinidiopathicintracranialhypertension